These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33274599)

  • 1. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Ben-Menachem S; Zaritsky A; Ehrlich M; Prieto VG; Bar-Eli M; Pirker C; Berger W; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Int J Cancer; 2015 Mar; 136(6):1296-307. PubMed ID: 25046141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis Suppressor NME1 Directly Activates Transcription of the
    Pamidimukkala NV; Leonard MK; Snyder D; McCorkle JR; Kaetzel DM
    Anticancer Res; 2018 Nov; 38(11):6059-6068. PubMed ID: 30396920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
    Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
    Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
    Maruyama R; Nagaoka Y; Ishikawa A; Akabane S; Fujiki Y; Taniyama D; Sentani K; Oue N
    Pathol Int; 2022 Mar; 72(3):176-186. PubMed ID: 35147255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
    Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
    Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
    Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
    Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
    Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of fructose-bisphosphate aldolase C expression as a predictor of advanced oral squamous cell carcinoma.
    Li YJ; Huang TH; Hsiao M; Lin BR; Cheng SJ; Yang CN; Lai WT; Wu TS; Fan JR; Kuo MY; Chang CC
    Head Neck; 2016 Apr; 38 Suppl 1():E1075-85. PubMed ID: 26565993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR4 is a determinant of melanoma brain metastasis.
    Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
    Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth.
    Fan K; Wang J; Sun W; Shen S; Ni X; Gong Z; Zheng B; Gao Z; Ni X; Suo T; Liu H; Liu H
    Exp Cell Res; 2020 Sep; 394(1):112118. PubMed ID: 32502493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
    Pozzi S; Scomparin A; Ben-Shushan D; Yeini E; Ofek P; Nahmad AD; Soffer S; Ionescu A; Ruggiero A; Barzel A; Brem H; Hyde TM; Barshack I; Sinha S; Ruppin E; Weiss T; Madi A; Perlson E; Slutsky I; Florindo HF; Satchi-Fainaro R
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35980743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.
    Izraely S; Ben-Menachem S; Malka S; Sagi-Assif O; Bustos MA; Adir O; Meshel T; Chelladurai M; Ryu S; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Cells; 2023 May; 12(11):. PubMed ID: 37296634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
    Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
    Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
    Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.